WEED, Inc. reported its financial results for the third quarter and the first nine months of 2025, revealing a continued lack of revenue and significant operating losses. For the three months ended September 30, 2025, the company recorded a net loss of $73,946, a decrease from a net loss of $95,887 in the same period of 2024. The nine-month figures showed a net loss of $622,018, compared to a loss of $377,492 for the same period last year. The company has not generated any revenue since its inception, and its total assets decreased to $532,267 from $738,366 at the end of 2024.

Operating expenses for the third quarter were $66,897, down from $92,649 in the prior year, primarily due to reductions in general and administrative expenses and professional fees. General and administrative expenses decreased to $58,519 from $64,833, while professional fees fell sharply to $193 from $22,195. However, total operating expenses for the nine months increased to $600,805 from $402,530, driven by a rise in general and administrative costs, which surged to $505,836 from $286,694.

The company’s balance sheet reflects a significant increase in current liabilities, which rose to $1,051,346 from $959,372 at the end of 2024. This increase was attributed to higher accounts payable and accrued officer compensation. WEED, Inc. ended the reporting period with only $400 in cash, a stark decline from $159,355 at the end of 2024, indicating a critical liquidity position. The company’s accumulated deficit has now reached $85,525,296.

Strategically, WEED, Inc. has been focusing on expanding its operations in the cannabis and hemp sectors. The company is pursuing various business opportunities, including the development of cultivation centers and research initiatives. Notably, it has made significant acquisitions, including Hempirical Genetics, which enhances its product offerings. However, the company acknowledges the need for additional financing to support its operations and growth plans, as it continues to seek capital from shareholders and other sources.

Looking ahead, WEED, Inc. remains committed to its long-term goal of becoming a "Seed-to-Sale" company in the cannabis industry. The management is actively exploring new products and services while emphasizing the importance of securing funding to achieve its objectives. The company’s future performance will depend on its ability to generate revenue and manage its financial obligations effectively.

About WEED, INC.

Weed, Inc. is a research-focused company developing cannabis and hemp-based products, including genetic studies, clinical trials, and proprietary strains for medical and therapeutic use. It operates globally with subsidiaries in Israel and Australia, aiming to advance cannabinoid-based treatments, genetic breeding, and infrastructure for the cannabis industry. The company emphasizes innovation, intellectual property, and compliance within evolving legal frameworks.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.